Navigation Links
NutraCea Announces First Quarter 2008 Financial Results
Date:5/12/2008

NUTRACEA AND SUBSIDIARIES

CONSOLIDATED CONDENSED BALANCE SHEETS

March 31, December 31,

2008 2007

(Unaudited)

ASSETS

Current assets:

Cash and cash equivalents $5,816,000 $41,298,000

Restricted cash 5,281,000 758,000

Trade accounts receivable,

net of allowance for doubtful

accounts of $3,168,000 and

$2,999,000, respectively 3,066,000 2,346,000

Inventories 3,831,000 1,808,000

Notes receivable, current portion,

net of allowance for doubtful notes

receivable of $543,000 and $250,000,

respectively 7,145,000 2,936,000

Deposits and other current assets 2,480,000 2,545,000

Total current assets 27,619,000 51,691,000

Restricted cash 1,791,000 1,791,000

Notes receivable, net of current portion 44,000 5,039,000

Property and equipment, net 38,939,000 19,328,000

Investment in joint venture 9,348,000 1,191,000

Patents and trademarks, net of

accumulated amortization 5,534,000 5,743,000

Other non-current 50,000 -

Goodwill 52,765,000 39,510,000

Total assets $136,090,000 $124,293,000

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:

Accounts payable and accrued liabilities $13,646,000 $7,506,000

De
'/>"/>

SOURCE NutraCea
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
2. NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14
3. NutraCea Announces Conference Call to Report Second Quarter Financial Results
4. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
5. NutraCea Provides Update on Domestic Operations
6. NutraCea Files Universal Shelf Registration Statement
7. NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America
8. New World Record Holder in Powerlifting Credits NutraCeas Unique Rice-Bran-derived Product as his Secret Weapon
9. NutraCea Appoints New Chief Financial Officer
10. NutraCea-Sponsored Study Demonstrates Benefits of Replacing Wheat Flour with Stabilized Rice Bran (SRB) in Battered and Fried Product Applications
11. Demand for NutraCea Rice Bran Oil Prompts Major Expansion of Irgovel Plant Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:'Supernanny' Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time To Talk(TM) 2Health News:'Supernanny' Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time To Talk(TM) 3Health News:UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Presented at American Society for Dermatologic Surgery Annual Meeting 2Health News:UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Presented at American Society for Dermatologic Surgery Annual Meeting 3Health News:Red wine and grape juice help defend against food-borne diseases, according to MU researchers 2Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 2Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 3Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 4Health News:Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals, Released at 2007 National Long Term Care Symposium 2Health News:Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals, Released at 2007 National Long Term Care Symposium 3Health News:Highmark's Hospital Pay-for-Performance Program Demonstrates Impressive Results 2Health News:Highmark's Hospital Pay-for-Performance Program Demonstrates Impressive Results 3
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Giant Eagle(R) Pharmacy Receives Award for Operational Excellence 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U S Army Medical Research Institute of Infectious Diseases 14973 1Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U S Army Medical Research Institute of Infectious Diseases 14973 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 6522 1Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 6522 2Maryland Woman Thankful for Wyeth Verdicts 6518 1Maryland Woman Thankful for Wyeth Verdicts 6518 2